Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapy

J Clin Psychiatry. 2007 Nov;68(11):1701-6. doi: 10.4088/jcp.v68n1109.

Abstract

Objective: To test whether antidepressant medication treatment failure predicts differential remission with electroconvulsive therapy (ECT) in nonpsychotic unipolar depression.

Method: Depressed patients diagnosed with the Structured Clinical Interview for DSM-IV receiving ECT were assessed for medication use with the Antidepressant Treatment History Form (ATHF) (N = 345). Response to ECT was assessed with the 24-item Hamilton Rating Scale for Depression. Baseline medication treatment failure was analyzed as a possible predictor of remission status. Dates of study enrollment were from May 1997 to July 2004.

Results: Resistance to antidepressant medication as assessed by the ATHF, either taken as a whole or for any individual class of medication, was not predictive of acute remission status with ECT.

Conclusion: Treatment failure with anti-depressant medication does not predict acute remission status with ECT for nonpsychotically depressed patients.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Antidepressive Agents / therapeutic use*
  • Depressive Disorder, Major / diagnosis
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / therapy*
  • Diagnostic and Statistical Manual of Mental Disorders
  • Drug Resistance*
  • Electroconvulsive Therapy / methods*
  • Female
  • Humans
  • Hypnotics and Sedatives / therapeutic use
  • Lorazepam / therapeutic use
  • Male
  • Psychomotor Agitation / prevention & control
  • Recurrence
  • Remission Induction
  • Sleep Initiation and Maintenance Disorders / prevention & control
  • Surveys and Questionnaires
  • Treatment Failure

Substances

  • Antidepressive Agents
  • Hypnotics and Sedatives
  • Lorazepam